570 related articles for article (PubMed ID: 25291139)
1. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans?
Mogna L; Pane M; Nicola S; Raiteri E
J Clin Gastroenterol; 2014; 48 Suppl 1():S91-5. PubMed ID: 25291139
[TBL] [Abstract][Full Text] [Related]
2. In vitro anti-inflammatory activity of selected oxalate-degrading probiotic bacteria: potential applications in the prevention and treatment of hyperoxaluria.
Giardina S; Scilironi C; Michelotti A; Samuele A; Borella F; Daglia M; Marzatico F
J Food Sci; 2014 Mar; 79(3):M384-90. PubMed ID: 24471378
[TBL] [Abstract][Full Text] [Related]
3. Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease.
Abratt VR; Reid SJ
Adv Appl Microbiol; 2010; 72():63-87. PubMed ID: 20602988
[TBL] [Abstract][Full Text] [Related]
4. Metabolic activity of probiotics-oxalate degradation.
Murphy C; Murphy S; O'Brien F; O'Donoghue M; Boileau T; Sunvold G; Reinhart G; Kiely B; Shanahan F; O'Mahony L
Vet Microbiol; 2009 Apr; 136(1-2):100-7. PubMed ID: 19028028
[TBL] [Abstract][Full Text] [Related]
5. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration.
Campieri C; Campieri M; Bertuzzi V; Swennen E; Matteuzzi D; Stefoni S; Pirovano F; Centi C; Ulisse S; Famularo G; De Simone C
Kidney Int; 2001 Sep; 60(3):1097-105. PubMed ID: 11532105
[TBL] [Abstract][Full Text] [Related]
6. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats.
Paul E; Albert A; Ponnusamy S; Mishra SR; Vignesh AG; Sivakumar SM; Sivasamy G; Sadasivam SG
Microbiol Res; 2018 Oct; 215():65-75. PubMed ID: 30172310
[TBL] [Abstract][Full Text] [Related]
7. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
Tavasoli S; Alebouyeh M; Naji M; Shakiba Majd G; Shabani Nashtaei M; Broumandnia N; Basiri A
BJU Int; 2020 Jan; 125(1):133-143. PubMed ID: 31145528
[TBL] [Abstract][Full Text] [Related]
8. Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria?
Hoppe B; von Unruh G; Laube N; Hesse A; Sidhu H
Urol Res; 2005 Nov; 33(5):372-5. PubMed ID: 16284877
[TBL] [Abstract][Full Text] [Related]
9. Effect of a Probiotic Supplement Containing Lactobacillus Acidophilus and Bifidobacterium Animalis Lactis on Urine Oxalate in Calcium Stone Formers with Hyperoxaluria: A Randomized, Placebo-controlled, Double-blind and In-vitro Trial.
Tavasoli S; Jalali S; Naji M; Borumandnia N; Shakiba Majd G; Basiri A; Khosravi Darani K; Karamad D; Tajabadi-Ebrahimi M; Taheri M
Urol J; 2021 Jun; 19(3):179-188. PubMed ID: 34129232
[TBL] [Abstract][Full Text] [Related]
10. Oxalobacter formigenes produces metabolites and lipids undetectable in oxalotrophic Bifidobacterium animalis.
Chamberlain CA; Hatch M; Garrett TJ
Metabolomics; 2020 Nov; 16(12):122. PubMed ID: 33219444
[TBL] [Abstract][Full Text] [Related]
11. Metabolomic profiling of oxalate-degrading probiotic Lactobacillus acidophilus and Lactobacillus gasseri.
Chamberlain CA; Hatch M; Garrett TJ
PLoS One; 2019; 14(9):e0222393. PubMed ID: 31545840
[TBL] [Abstract][Full Text] [Related]
12. Hyperoxaluria, hypocitraturia, hypomagnesiuria, and lack of intestinal colonization by Oxalobacter formigenes in a cervical spinal cord injury patient with suprapubic cystostomy, short bowel, and nephrolithiasis.
Vaidyanathan S; von Unruh GE; Watson ID; Laube N; Willets S; Soni BL
ScientificWorldJournal; 2006 Apr; 6():2403-10. PubMed ID: 17619709
[TBL] [Abstract][Full Text] [Related]
13. Analysis and Characterization of Lactobacillus paragasseri and Lacticaseibacillus paracasei: Two Probiotic Bacteria that Can Degrade Intestinal Oxalate in Hyperoxaluric Rats.
Mehra Y; Rajesh NG; Viswanathan P
Probiotics Antimicrob Proteins; 2022 Oct; 14(5):854-872. PubMed ID: 35699895
[TBL] [Abstract][Full Text] [Related]
14. Oxalate consumption by lactobacilli: evaluation of oxalyl-CoA decarboxylase and formyl-CoA transferase activity in Lactobacillus acidophilus.
Turroni S; Vitali B; Bendazzoli C; Candela M; Gotti R; Federici F; Pirovano F; Brigidi P
J Appl Microbiol; 2007 Nov; 103(5):1600-9. PubMed ID: 17953571
[TBL] [Abstract][Full Text] [Related]
15. Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?
Peck AB; Canales BK; Nguyen CQ
Urolithiasis; 2016 Feb; 44(1):45-50. PubMed ID: 26645869
[TBL] [Abstract][Full Text] [Related]
16. [Effect of oral lactosucrose supplementation on human enteric oxalate-degrading bacteria].
Takei K; Akakura K; Ueda T; Mikami K; Ito H
Hinyokika Kiyo; 2006 Sep; 52(9):687-91. PubMed ID: 17040052
[TBL] [Abstract][Full Text] [Related]
17. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
Hütt P; Shchepetova J; Lõivukene K; Kullisaar T; Mikelsaar M
J Appl Microbiol; 2006 Jun; 100(6):1324-32. PubMed ID: 16696680
[TBL] [Abstract][Full Text] [Related]
18. Role of gut microbiota against calcium oxalate.
Sadaf H; Raza SI; Hassan SW
Microb Pathog; 2017 Aug; 109():287-291. PubMed ID: 28624518
[TBL] [Abstract][Full Text] [Related]
19. Assessment of in vitro oxalate degradation by Lactobacillus species cultured from veterinary probiotics.
Cho JG; Gebhart CJ; Furrow E; Lulich JP
Am J Vet Res; 2015 Sep; 76(9):801-6. PubMed ID: 26309108
[TBL] [Abstract][Full Text] [Related]
20. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.
Siva S; Barrack ER; Reddy GP; Thamilselvan V; Thamilselvan S; Menon M; Bhandari M
BJU Int; 2009 Jan; 103(1):18-21. PubMed ID: 19021605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
